Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag
- PMID: 16427108
- DOI: 10.1016/j.virol.2005.12.012
Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag
Abstract
We have investigated the properties of murine leukemia virus Gag mutants in which the p12-CA cleavage site is altered. In one mutant, the cleavage is blocked; in the other, the conserved proline at the N-terminus of CA has been replaced with glycine. No infectivity was detected in either mutant. Mutant particles cannot synthesize full-length DNA upon infecting permissive cells. Particles composed of a mixture of wild-type and mutant proteins have severely impaired infectivity. These mixed particles are defective in their ability to synthesize DNA upon infection, but this defect is less severe than the loss of infectivity. Thus, proteins lacking the correct N-terminus of CA inhibit DNA synthesis and also interfere with formation or integration of a full-length, normal provirus. The results imply that CA proteins function as part of a large, highly organized structure in reverse transcription and apparently at a later step as well.
Similar articles
-
Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.J Virol. 2005 Apr;79(7):4159-69. doi: 10.1128/JVI.79.7.4159-4169.2005. J Virol. 2005. PMID: 15767417 Free PMC article.
-
The N-terminus of murine leukaemia virus p12 protein is required for mature core stability.PLoS Pathog. 2014 Oct 30;10(10):e1004474. doi: 10.1371/journal.ppat.1004474. eCollection 2014 Oct. PLoS Pathog. 2014. PMID: 25356837 Free PMC article.
-
Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.Virology. 2000 Mar 15;268(2):294-307. doi: 10.1006/viro.1999.0178. Virology. 2000. PMID: 10704338
-
Operating under a Gag order: a block against incoming virus by the Fv1 gene.Cell. 1996 Sep 6;86(5):691-3. doi: 10.1016/s0092-8674(00)80141-5. Cell. 1996. PMID: 8797814 Review. No abstract available.
-
Correlates of immune protection after vaccination with attenuated live murine leukemia virus.AIDS Res Hum Retroviruses. 1996 Mar 20;12(5):375-7. doi: 10.1089/aid.1996.12.375. AIDS Res Hum Retroviruses. 1996. PMID: 8882313 Review. No abstract available.
Cited by
-
A Direct Interaction with RNA Dramatically Enhances the Catalytic Activity of the HIV-1 Protease In Vitro.J Mol Biol. 2015 Jul 17;427(14):2360-78. doi: 10.1016/j.jmb.2015.05.007. Epub 2015 May 15. J Mol Biol. 2015. PMID: 25986307 Free PMC article.
-
A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle.J Virol. 2009 Sep;83(17):8536-43. doi: 10.1128/JVI.00317-09. Epub 2009 Jun 10. J Virol. 2009. PMID: 19515760 Free PMC article.
-
Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag.PLoS One. 2010 Jun 24;5(6):e11304. doi: 10.1371/journal.pone.0011304. PLoS One. 2010. PMID: 20585587 Free PMC article.
-
Mutational analysis of the N-terminal domain of Moloney murine leukemia virus capsid protein.J Virol. 2007 Nov;81(22):12337-47. doi: 10.1128/JVI.01286-07. Epub 2007 Sep 12. J Virol. 2007. PMID: 17855544 Free PMC article.
-
Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: effects on virion morphogenesis and RNA maturation.Virology. 2008 Sep 15;379(1):152-60. doi: 10.1016/j.virol.2008.06.030. Epub 2008 Jul 26. Virology. 2008. PMID: 18657842 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
